AstraZeneca prices a $2.25bn bond offering
1 March 2023 07:00 GMT AstraZeneca prices a $2.25bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a three tranche global bond offering totalling $2.25bn on 28 February 2023. The offering is expected to close on 3 March 2023, subject to customary closing conditions. The transaction, which is a global offering registered with the US Securities and Exchange Commission ("SEC"), consists of the following three tranches: Notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by